Search Results - "Collins, Ashté"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    When end‐stage kidney disease complicates abdominal surgery by Lew, Susie Q., Collins, Ashté

    Published in Seminars in dialysis (01-05-2020)
    “…Patients receiving peritoneal dialysis (PD) encounter an increased risk for infection, bleeding, and PD fluid leakage after abdominal surgery. These…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Donor-derived Cell-free DNA: Advancing a Novel Assay to New Heights in Renal Transplantation by Paul, Rohan S., Almokayad, Ismail, Collins, Ashte, Raj, Dominic, Jagadeesan, Muralidaran

    Published in Transplantation direct (01-03-2021)
    “…Despite advances in transplant immunosuppression, long-term renal allograft outcomes remain suboptimal because of the occurrence of rejection, recurrent…”
    Get full text
    Journal Article
  4. 4

    Utilization of Potassium Binders for the Management of Hyperkalemia in Chronic Kidney Disease: A Position Statement by US Nephrologists by Rastogi, Anjay, Chertow, Glenn M., Collins, Ashté, Kelepouris, Ellie, Kotzker, Wayne, Middleton, John P., Rajpal, Minesh, Roy-Chaudhury, Prabir

    “…Two potassium (K+) binders—patiromer sorbitex calcium and sodium zirconium cyclosilicate—are recommended by international guidelines for the management of…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    SO046REGULATION OF GUT MICROBIOTA AND HOST CO-METABOLISM BY POTASSIUM HOMEOSTASIS IN PATIENTS ON HEMODIALYSIS by Raj, Dominic, Gao, Bei, Barrows, Elizabeth, Jagadeesan, Muralidharan, Amdur, Richard, Collins, Ashte, Regunathan-Shenk, Renu, Kincaid, Danielle, Omar, Badryah, Siddiqi, Muhammad

    Published in Nephrology, dialysis, transplantation (01-06-2020)
    “…Abstract Background and Aims Gut microbiota composition is dysregulated in hemodialysis patients. However, the impact of potassium homeostasis on the gut…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Safety and dose-finding study of activated protein C (drotrecogin alfa activated) as an anticoagulant in end-stage renal disease patients treated with hemodialysis by Brasha-Mitchell, Ermira, Collins, Ashte, Shehu, Lindita, Seneff, Michael G, Patel, Samir S, Chawla, Lakhmir S

    Published in Blood purification (2014)
    “…End-stage renal disease (ESRD) patients treated with hemodialysis (HD) experience a high risk of death. ESRD patients with elevated levels of pro-inflammatory…”
    Get more information
    Journal Article